Cargando…
Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry
Type 1 diabetes (T1D) is a metabolic disease caused by the autoimmune destruction of insulin-producing β-cells. With its incidence increasing worldwide, to find a safe approach to permanently cease autoimmunity and allow β-cell recovery has become vital. Relying on the inherent ability of apoptotic...
Autores principales: | Rodriguez-Fernandez, Silvia, Pujol-Autonell, Irma, Brianso, Ferran, Perna-Barrull, David, Cano-Sarabia, Mary, Garcia-Jimeno, Sonia, Villalba, Adrian, Sanchez, Alex, Aguilera, Eva, Vazquez, Federico, Verdaguer, Joan, Maspoch, Daniel, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817077/ https://www.ncbi.nlm.nih.gov/pubmed/29491866 http://dx.doi.org/10.3389/fimmu.2018.00253 |
Ejemplares similares
-
Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes
por: Pujol-Autonell, Irma, et al.
Publicado: (2015) -
Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2019) -
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
por: Villalba, Adrian, et al.
Publicado: (2020) -
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
por: Villalba, Adrian, et al.
Publicado: (2020) -
Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
por: Pujol-Autonell, Irma, et al.
Publicado: (2013)